Contributed to TLB by: Christina England
Aluminum has been linked to diseases such as cancer, autism, and Alzheimer’s. This toxic material is entering the human body via everyday consumption of food, water, cosmetics and an increasing number of vaccinations.
Aluminum has been named as the second most used metal in the world after steel, largely because it is so versatile. It can be found in our food, drinking water, atmosphere, medication, vaccinations and cosmetics.
According to U.S. Department of Energy, the United States’ aluminum industry is the world’s largest, processing 9.6 million metric tons of metal and producing about $40 billion in products and exports in 2003.
However, despite its versatility and its many uses, aluminum has become one of most negatively talked about products used today. In recent months, scientists have linked its use to cancer, autism, Alzheimer’s disease and chemical burns.
So, what is being done to protect the public from its many dangers?
Aluminum is Toxic and Potentially Harmful to Humans
Professor Christopher Exley, often referred to as Mr. Aluminum, has been studying the effects of aluminum on the human body for thirty years and has become increasingly worried. In a recent video presentation, he explained that, despite the fact that aluminum has been regularly used as an adjuvant in vaccination for many years, little is known about its effect on the human body. He made it clear that we should accept that aluminum is toxic and that toxicity may take many different forms. He stated that wherever it ends up in the body, it has the potential to do harm.
This is certainly something to consider, especially when none of us can be certain where an aluminum adjuvant will accumulate once it has been vaccinated into our body.
Professor Exley continued by stating that:
If aluminum is in the brain, it can produce neurodegeneration and problems associated with the brain; if it is in the bone, it can produce bone disease. Wherever it ends up in the body, it has the potential to cause toxicity, whether it is in humans, fish or any other living organism.
Taking this a little bit further, Professor Exley explained that it is possible for two individuals to have very similar amounts of aluminum in their body and for only one of them to suffer an adverse effect, which he says could be due to individual physiology, medical history and genetics.
Speaking about the different ways in which the body can absorb aluminum, Professor Exley talked about the gut, the lungs, the nose and the skin before moving on to the subject of vaccination and adjuvants. He stated that we must understand that aluminum exposure in this form is very different from any other form of exposure.
Discussing his work, he said:
Currently, we are researching the simple things. For example, when you inject an adjuvant, what is its fate? What happens to it? What happens to it, relative to the antigen that it was injected with?
We are about to be able to publish what we believe is for the first time unequivocal evidence that, yes, immune cells do come to the site of the injection, they do take up aluminum particles and they will transport them elsewhere.
Professor Exley continued:
In other words, once you have been vaccinated with a vaccine containing an aluminum adjuvant at an injection site, there is the potential for it to go anywhere in the body and if it is such an effective adjuvant at an injection site, then could it not be an equally effective adjuvant elsewhere? In other words, if particulate aluminum gets carried into the brain or into another organ, then it could have the potential to act as an adjuvant there, couldn’t it? Could it not induce the type of inflammatory response that you see at the site of an injection in any other type of tissue where that adjuvant material ends up, simply because it’s been carried there?
If Professor Exley is correct, could his research explain why so many babies develop encephalitis (inflammation of the brain) shortly after receiving multiple vaccinations containing aluminum?
Number of Vaccinations Containing Aluminum is on the Rise
Dr. Lucija Tomljenovic, a scientist working at the University of British Columbia, Canada, believes that the level of aluminum children receive in their diet and childhood vaccinations is far in excess of the safe levels recommended.
In a paper that she wrote in 2010, titled Aluminum and Alzheimer’s Disease: After a Century of Controversy, Is there a Plausible Link?, she explained that the blood brain barrier (BBB) in young children is immature, making them more susceptible to toxic substances.
She stated that:
According to the latest vaccination schedule, every child in the USA will receive a total of 5–6 mg of Al by the age of 2 years, or up to 1.475 mg of Al during a single visit to the pediatrician (Table 6). This is contrary to the upper limit of 5µg Al/kg/day set by the Food and Drug Administration (FDA) for premature neonates and individuals with impaired kidney function. Healthy neonates may be able to handle more Al, however, there are no such studies available upon which we could safely estimate acceptable upper levels of Al from parenteral or injectable sources in healthy children. In that respect, it is worth noting that the FDA document states that Al accumulation at levels associated with central nervous system and bone toxicity may occur at even lower rates of exposure.
Reading through her detailed vaccination schedules, you will see that the amount of aluminum a small baby can receive in just one visit to the doctor’s office is of great concern.
According to her vaccination charts, a child aged two months is scheduled to receive the following vaccinations:
- Hepatitis BRotavirus
- DPT (diphtheria, pertussis, tetanus)
- Hib (haemophilus influenzae type b)
- PCV (pneumococcal conjugate vaccine)
- IPV (polio vaccination)
Using the figures supplied by Dr. Tomljenovic in her paper, in just one visit, an eight week-old baby could receive vaccinations containing a cumulative sum of 1.225 – 1.475 mg of aluminum, an amount well in excess of the FDA’s recommendations.
If children are receiving well in excess of the recommended doses of aluminum per visit to the doctor, plus the high doses of aluminum in their food and drinking water, then it is fairly safe to assume that if this pattern continues to old age, combined with the aluminum used in other products such as medication and cosmetics, then the long-term effect on the brain could be catastrophic, especially to an elderly person.
Aluminum Loaded Vaccines Linked to Autism
A further study conducted by Canadian scientists Professor Christopher Shaw and Dr. Lucija Tomljenovic revealed that the more vaccines that children receive containing the adjuvant aluminum, the greater their chance is of developing autism, autoimmune diseases and neurological problems in the future.
In 2013, in their paper, published by Springer Science+Business Media, titled Aluminum in the Central Nervous System (CNS): Toxicity in Humans and Animals, Vaccine Adjuvants, and Autoimmunity, they revealed that during a 17-year period, the rates of autism had increased significantly in countries that had the most vaccinations containing the adjuvant aluminum.
A Highly Significant Correlation
The researchers compared the number of vaccines recommended by the Centers for Disease Control and Prevention (CDC) during the period from 1991 – 2008 and the changes in the autism rates during the same period.
The data sets, graphed against each other, show a pronounced and statistically highly significant correlation between the number vaccines with aluminum and the changes in autism rates. Further data showed that a significant correlation exists between the amounts of aluminum given to preschool children and the current rates of autism in seven Western countries. Those countries with the highest level of aluminum-adjuvanted vaccines had the highest autism rates. (own emphasis)
They revealed that:
The observed correlation between the number of aluminum-adjuvanted vaccines and ASD was further tested using Hill’s criteria and met eight of nine of these indicating that vaccines containing aluminum are highly likely to be at least partially causal for autism.
For those who are not familiar with ‘Hill’s criteria,’ it is a technique used to determine a causal link between a specific factor and a disease. For example, does excess smoking cause lung cancer? Scientists seeking “to establish a valid causal connection between a potential disease agent” now frequently use the technique, which was first developed by British medical statistician Austin Bradford Hill.
Professor Shaw and Dr. Tomljenovic continued their paper by adding that:
There are other links between aluminum exposure/toxicity and ASD. These include the following: A pilot study showed higher than normal aluminum levels in the hair, blood and/or urine of autistic children; children are regularly exposed to higher levels of aluminum in vaccines per body weight than adults; practically, nothing is known about the pharmacokinetics and toxicodynamics of aluminum in vaccines in children; and aluminum in vaccines has been linked to serious neurological impairments, chronic fatigue and autoimmunity.
If Professor Shaw and Dr. Tomljenovic are correct, then their results are extremely worrying, especially as autism is not the only condition to which their paper linked the adjuvant aluminum.
In fact, their paper also linked aluminum to the rise in the incidence of Alzheimer’s disease, Gulf War syndrome and a relatively new syndrome, ASIA (autoimmune/inflammatory syndrome induced by adjuvants), that was identified by scientists in 2011.
What is the Answer?
In 2006, Professor Exley and his team wrote a paper titled Non-invasive therapy to reduce the body burden of aluminium in Alzheimer’s, in which the team discussed ways to reduce the body burden of aluminum in patients with Alzheimer’s disease.
They wrote that:
Based upon the premise that urinary aluminium is the best non-invasive estimate of body burden of aluminium patients with Alzheimer’s disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined.
For the purpose of their study, the team used the mineral water Volvic, because of its high concentrations of the mineral silicic acid, which Professor Exley says can reduce body burden of aluminum through the urine if drank regularly. He believed that by reducing the body burden of aluminum in patients with Alzheimer’s disease, this process may slow down the diseases progression.
On page 18 of the paper they wrote that:
The primary objective in Week 1 was to obtain an estimate of the patient’s normal urinary Al excretion. Patients were provided with pristine airtight sample bottles and asked to collect their first urine of each of five consecutive days. It was neither practical nor ethically acceptable to ask patients to collect 24 hour urine samples. However, the use of ‘spot’ samples to estimate urinary Al excretion was validated as explained in Section 2.2 below. The urine samples were stored in appropriate biohazard bags in the patient’s refrigerator
before being collected, transported to the laboratory and frozen at −20◦C. In Week 2 patients were asked to drink up to 1.5 L of silicic acid-rich mineral water (hereafter referred to by its brand name ‘Volvic’) per day for each of five consecutive days. Once again, beginning with the first day which followed drinking the first 1.5 L of Volvic, the patients were asked to collect their first urine sample of the day and to repeat this for five consecutive days. Storage, collection, transport and treatment of urine samples were as per Week 1. In this way we collected five pre-Volvic (Week 1) and five post-Volvic (Week 2) urine samples for each
of the ten patients. Patients completed record cards on which they indicated how much Volvic they drank on each day and whether or not they drank it neat or used it to make other beverages. Patients were not asked to drink the 1.5 L of Volvic as an additional constituent of their daily diets but to include it as part of their diets for that week. Apart from drinking Volvic in Week 2 the patients were encouraged to carry out their normal daily routines and to adhere to their usual diets.
The results of their study were reported to be very encouraging and have spurred the team to do more work in the future.
The team concluded that:
We have carried out the first study to determine if silicic acid in a potable water might be used to reduce the body burden of Al in individuals with AD. While the small number of participants must imply that our results are preliminary the statistical significance achieved for the Volvic-facilitated reduction of the body burden of Al is encouraging and future research will both increase the number of study participants and extend the period of time over which therapy is administered. A final aim is, of course, to determine if lowering the body burden of Al has any influence upon the incidence, progression and aetiology of AD.
If it is possible to influence the progression of Alzheimer’s disease, might it be possible to slow down the progression of other neurological disorders, including autism?
Parents State Vaccine-Injured Daughters are Improving
Another vaccine known to contain the adjuvant aluminum is the human papillomavirus vaccination (HPV). In 2011, Professor Exley spoke to professionals at a conference on vaccination safety, where once again he mentioned his work on aluminum and mineral water.
At approximately 47 minutes 45 seconds in the video, he stated:
Like many of you, I am contacted on a regular basis by people who have been adversely affected, sometimes by vaccination and other aluminum-related issues. I have been contacted by parents of girls who have taken the human papillomavirus vaccination and they have said, is there anything we can do, has it got anything to do with aluminum? I don’t tell them it’s got anything to do with aluminum, that is not my role, I am not a doctor. I would simply tell them look, if there is anything to do with aluminum, try taking a silicon-rich mineral water, I tell them which one. I am increasingly getting emails back six months, a year later, telling me their daughter is better. I am not making this up. Their daughter is better; I say well, it might have had something to do with that, it might be something else that you are doing, but that’s great news. So, anecdotally, at least we’re getting good results here; we need, of course, to get proper scientific data as well for people potentially getting better, simply by drinking a silicon-rich mineral water. (words taken from the video)
If Professor Exley is correct, then this could mean that something as simple as drinking silicon-rich mineral water may have the potential to help many other vaccine injured children including those children with autism.
Sadly, to enable scientists such as Professor Exley and his team to gain the scientific data and knowledge required, they would need this research to be funded.
Public Appeal for Exciting New Research
On July 14, 2015, Professor Exley is launching an appeal to the public titled The Peoples Trial The First Clinical Trial to Test the Aluminium / Alzheimer’s Disease Hypothesis to enable further research to proceed. In his video, he explained that as yet, a cure for Alzheimer’s disease has not been found. This is because scientists do not know the cause of the disease. He believes that if he and his team were able to carry out further research on the known links between Alzheimer’s disease and aluminum, then it may be possible to slow down the progression of the disease.
He stated that:
One factor which has been linked to Alzheimer’s disease for actually 50 years now is human exposure to aluminum, exposure to aluminum in our everyday life. However, in all that time there has never been a clinical trial to test whether our exposure to aluminum in our everyday life contributes to Alzheimer’s disease. The idea therefore in this trial, is to test this hypothesis, that aluminum has a role to play in the disease.
Professor Exley explained how he and his team propose to recruit individuals suffering from the early stages of Alzheimer’s disease and ask them to drink a litre of silicon-rich mineral water every day for two years and monitor the progress of their disease.
If this trial is successful, for example in demonstrating a role of aluminum in Alzheimer’s disease, then not only will we have shown that aluminum plays a role but we will have an effective treatment, we will have the first effective treatment.
Of course, if the team is successful, then their work could potentially pave the way for further trials examining the link between aluminum and other neurological conditions, including autism, Tourette syndrome and epilepsy.
Sadly, as yet, Professor Exley has been unable to secure the necessary funding that he and his team would require to carry out such a trial and he now believes that an appeal to the public may be only the way that they will be able to carry out their work.
In a press release advertising the appeal he stated that:
This is why we are asking for the public’s help to support and fund a clinical trial which will establish once and for all if human exposure to aluminum is a contributory factor in Alzheimer’s disease.
Full details of the proposed clinical trial, the funding required to carry it out and how the public can support the trial by making a donation are all available through the following website;
Further details about this appeal and the proposed trial can be found at the link below.
Christina was born and educated in London, U.K. She received an A Level in Psychology and a BTEC in Learning Disabilities. She has spent many years researching vaccines and adverse reactions. She has an HND in journalism and media and is currently writing for the American Chronicle, the Weekly Blitz, The Liberty Beacon project and Vaccination Truth on immunization safety and efficacy.
TLB recommends you visit GreenMedInfo (original site of publication) for more pertinent articles and information.
TLB also recommends you visit Children’s Medical Safety Research Institute (CMSRI) for more pertinent information.